1. Home
  2. RFL

RFL

Rafael Holdings Inc. Class B

Logo Rafael Holdings Inc. Class B

Finance

Real Estate

Nasdaq

as 04-12-2024 9:40am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.

Founded: N/A Country:
United States
United States
Employees: N/A City: NEWARK
Market Cap: 41.5M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 27.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.10 EPS Growth: N/A
52 Week Low/High: $1.44 - $2.52 Next Earning Date: 06-11-2024
Revenue: $275,000 Revenue Growth: -3.51%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: